ClinicalTrials.gov
public full text
Public Domain
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
This pilot study compares two photosensitizers, hexylaminolaevulinate (HAL) and methylaminolaevulinate (MAL), in treatment of actinic keratoses. Study is conducted using randomized split-face design. Efficacy is assessed clinically, and histologically at 3 and 12 months. Pain during and after treatments and adverse reactions at one week are recorded.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Treatment of Actinic Keratoses With Photodynamic Therapy Using Sunlight Versus Red Light#911287
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses#1172478
- Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis#889663
- Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses#1171787
- Daylight Photodynamic Therapy for Actinic Keratosis#851762
Record · ID 1087576
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive